(Q50980365)

26 March 2018

title

The differential effect of illicit drug use on cognitive function in first-episode psychosis and healthy controls. (English)

1 reference

26 March 2018

1 reference

8

1 reference

26 March 2018

Peter B. Jones

9

1 reference

26 March 2018

Kim Donoghue

object named as

K Donoghue

1

0 references

Craig Morgan

object named as

C Morgan

5

0 references

Paola Dazzan

object named as

P Dazzan

6

0 references

author name string

R Mazzoncini

2

1 reference

26 March 2018

J Hart

3

1 reference

26 March 2018

J Zanelli

4

1 reference

26 March 2018

K D Morgan

7

1 reference

26 March 2018

G A Doody

10

1 reference

26 March 2018

language of work or name

English

0 references

publication date

30 November 2011

1 reference

26 March 2018

Acta Psychiatrica Scandinavica

published in

1 reference

26 March 2018

volume

125

1 reference

26 March 2018

issue

5

1 reference

26 March 2018

page(s)

400-411

1 reference

26 March 2018

Neuropsychological functioning in first-episode schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Neurological abnormalities and cognitive ability in first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Comorbid substance use and age at onset of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

High-potency cannabis and the risk of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Illicit substance use and its correlates in first episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

The incidence of schizophrenia in Nottingham.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Heterogeneity in Incidence Rates of Schizophrenia and Other Psychotic Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

The national survey of psychiatric morbidity in Great Britain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Duration of untreated psychosis and ethnicity in the AESOP first-onset psychosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: influence of dual diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Cannabis use disorders in schizophrenia: effects on cognition and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Substance misuse and cognitive functioning in early psychosis: a 2 year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Neural substrates of faulty decision-making in abstinent marijuana users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Abnormal brain activity in prefrontal brain regions in abstinent marijuana users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

The chronic effects of cannabis on memory in humans: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Executive function deficits in short-term abstinent cannabis users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Cannabis, cannabinoids and schizophrenia: integration of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

The role of cannabis in cognitive functioning of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Validation of self-reported cannabis use by urine analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Neuropsychological performance of recently abstinent alcoholics and cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Cognitive deficits as a function of years of alcohol abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

Psychological deficit from excessive alcohol consumption: evidence from a co-twin control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2011.01803.X

10.1111/J.1600-0447.2011.01803.X

21 January 2018

Identifiers

DOI

1 reference

26 March 2018

release_pgj4et72brefrkvw4tpgr7y2by

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pgj4et72brefrkvw4tpgr7y2by

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

26 March 2018